This prospective, open-label study evaluated the early effects of low-dose growth hormone replacement (GHR) on body composition and quality of life (QoL) in adults with growth hormone deficiency (AGHD). Patients received daily GH doses of 0.4–0.5 IU, titrated to maintain IGF-I levels between the median and upper end of the
